Company Quick10K Filing
Envista
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-10-24 Quarter: 2019-09-27
S-1 2019-07-22 Public Filing
8-K 2019-12-18 Officers
8-K 2019-12-18 Control, Regulation FD, Exhibits
8-K 2019-10-24 Earnings, Regulation FD, Exhibits
8-K 2019-09-18 Enter Agreement, Off-BS Arrangement, Officers, Amend Bylaw, Code of Ethics, Regulation FD, Exhibits
NVST 2019-09-27
Note 1. Business Overview and Basis of Presentation
Note 2. Revenue
Note 3. Leases
Note 4. Goodwill
Note 5. Fair Value Measurements
Note 6. Financing
Note 7. Hedging Transactions and Derivative Financial Instruments
Note 8. Defined Benefit Plans
Note 9. Accrued Expenses and Other Liabilities
Note 10. Income Taxes
Note 11. Commitments and Contingencies
Note 12. Stock Transactions and Stock-Based Compensation
Note 13. Net Earnings per Share
Note 14. Segment Information
Note 15. Related-Party Transactions
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
Part II - Other Information
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 6. Exhibits
EX-31.1 nvst-92719xex311.htm
EX-31.2 nvst-92719xex312.htm
EX-32.1 nvst-92719xex321.htm
EX-32.2 nvst-92719xex322.htm

Envista Earnings 2019-09-27

NVST 10Q Quarterly Report

Balance SheetIncome StatementCash Flow

Comparables ($MM TTM)
Ticker M Cap Assets Liab Rev G Profit Net Inc EBITDA EV G Margin EV/EBITDA ROA
SBFM 0 0 1 0 0 -2 -2 -0 23% 0.0 -1,974%
UGRO
TRWH
VERY
VIE
VIR
WORK
XTEG
DGTW 0 0 3 -0 -0 -6 -4 -0 12,618% 0.0 -16,557%
QPAG 0 1 5 9 0 -3 -0 -0 1% 0.2 -259%

Document
false--12-31Q3201900017570733752000003942000000.01100500000000.01001587000001001587000000.130.120.08006000000006500000000.0120.035P3YP3Y53000000150000000000 0001757073 2019-01-01 2019-09-27 0001757073 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-27 0001757073 2019-10-18 0001757073 2018-12-31 0001757073 2019-09-27 0001757073 2018-01-01 2018-09-28 0001757073 2018-06-30 2018-09-28 0001757073 2019-06-29 2019-09-27 0001757073 us-gaap:OtherAdditionalCapitalMember 2019-06-29 2019-09-27 0001757073 us-gaap:AdditionalPaidInCapitalMember 2019-06-29 2019-09-27 0001757073 us-gaap:RetainedEarningsMember 2018-09-28 0001757073 us-gaap:OtherAdditionalCapitalMember 2018-01-01 2018-09-28 0001757073 us-gaap:RetainedEarningsMember 2017-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-29 2019-09-27 0001757073 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-27 0001757073 us-gaap:CommonStockMember 2018-09-28 0001757073 us-gaap:CommonStockMember 2019-06-29 2019-09-27 0001757073 us-gaap:OtherAdditionalCapitalMember 2019-09-27 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-28 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-09-28 0001757073 us-gaap:AdditionalPaidInCapitalMember 2018-06-29 0001757073 us-gaap:OtherAdditionalCapitalMember 2019-01-01 2019-09-27 0001757073 us-gaap:CommonStockMember 2019-09-27 0001757073 us-gaap:NoncontrollingInterestMember 2018-12-31 0001757073 us-gaap:RetainedEarningsMember 2018-06-29 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-28 0001757073 us-gaap:AdditionalPaidInCapitalMember 2018-09-28 0001757073 us-gaap:CommonStockMember 2018-06-29 0001757073 us-gaap:RetainedEarningsMember 2019-06-28 0001757073 us-gaap:OtherAdditionalCapitalMember 2018-06-30 2018-09-28 0001757073 us-gaap:RetainedEarningsMember 2019-09-27 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-27 0001757073 us-gaap:NoncontrollingInterestMember 2018-06-29 0001757073 us-gaap:RetainedEarningsMember 2019-06-29 2019-09-27 0001757073 us-gaap:NoncontrollingInterestMember 2019-06-29 2019-09-27 0001757073 us-gaap:NoncontrollingInterestMember 2019-09-27 0001757073 us-gaap:OtherAdditionalCapitalMember 2018-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2019-09-27 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 2018-09-28 0001757073 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-09-28 0001757073 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-09-27 0001757073 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-27 0001757073 us-gaap:NoncontrollingInterestMember 2018-06-30 2018-09-28 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001757073 us-gaap:OtherAdditionalCapitalMember 2018-09-28 0001757073 us-gaap:OtherAdditionalCapitalMember 2018-06-29 0001757073 us-gaap:NoncontrollingInterestMember 2018-09-28 0001757073 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001757073 us-gaap:OtherAdditionalCapitalMember 2017-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-27 0001757073 us-gaap:CommonStockMember 2018-12-31 0001757073 2018-09-28 0001757073 us-gaap:RetainedEarningsMember 2018-12-31 0001757073 us-gaap:NoncontrollingInterestMember 2019-06-28 0001757073 us-gaap:AdditionalPaidInCapitalMember 2019-06-28 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-29 0001757073 us-gaap:NoncontrollingInterestMember 2017-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001757073 us-gaap:CommonStockMember 2019-06-28 0001757073 us-gaap:CommonStockMember 2017-12-31 0001757073 us-gaap:OtherAdditionalCapitalMember 2018-01-01 0001757073 us-gaap:OtherAdditionalCapitalMember 2019-06-28 0001757073 us-gaap:CommonStockMember 2019-01-01 2019-09-27 0001757073 2017-12-31 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-06-28 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2018-06-30 2018-09-28 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-06-30 2018-09-28 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2018-09-28 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-09-28 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-09-27 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-06-30 2018-09-28 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-06-29 2019-09-27 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-28 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-29 2019-09-27 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-29 2019-09-27 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-06-29 0001757073 2018-06-29 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-28 0001757073 2019-06-28 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-09-27 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2018-06-29 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-06-29 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-27 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-09-28 0001757073 us-gaap:IPOMember 2019-01-01 2019-09-27 0001757073 2019-01-01 0001757073 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-27 0001757073 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-27 0001757073 us-gaap:IPOMember 2019-09-20 2019-09-20 0001757073 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-06-29 2019-09-27 0001757073 us-gaap:IPOMember 2019-09-27 0001757073 2019-09-20 2019-09-20 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-09-28 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-01-01 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-09-27 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-27 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-09-28 0001757073 2018-01-01 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-01-01 2018-01-01 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-01-01 2018-09-28 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-09-27 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-12-31 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2017-12-31 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-01-01 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-01-01 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 0001757073 2018-01-01 2018-01-01 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001757073 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-06-30 2018-09-28 0001757073 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-09-28 0001757073 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-12-31 0001757073 nvst:HighgrowthmarketsMember 2019-01-01 2019-09-27 0001757073 srt:NorthAmericaMember 2019-01-01 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember nvst:EquipmentandConsumablesMember 2019-01-01 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember nvst:RevenuefromContractwithCustomerMeasurementNonrecurringMember nvst:SpecialtyProductsandTechnologiesMember 2019-01-01 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember nvst:WesternEuropeMember nvst:SpecialtyProductsandTechnologiesMember 2019-01-01 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2018-01-01 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:HighgrowthmarketsMember nvst:EquipmentandConsumablesMember 2018-01-01 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:RevenuefromContractwithCustomerMeasurementNonrecurringMember nvst:EquipmentandConsumablesMember 2018-01-01 2018-09-28 0001757073 nvst:WesternEuropeMember 2019-01-01 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember nvst:OtherdevelopedmarketsMember nvst:EquipmentandConsumablesMember 2019-01-01 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember nvst:SpecialtyProductsandTechnologiesMember 2018-01-01 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:HighgrowthmarketsMember nvst:SpecialtyProductsandTechnologiesMember 2019-01-01 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember nvst:RevenuefromContractwithCustomerMeasurementRecurringMember nvst:EquipmentandConsumablesMember 2019-01-01 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember nvst:RevenuefromContractwithCustomerMeasurementRecurringMember nvst:SpecialtyProductsandTechnologiesMember 2019-01-01 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2018-01-01 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2019-01-01 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember nvst:OtherdevelopedmarketsMember nvst:SpecialtyProductsandTechnologiesMember 2018-01-01 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:WesternEuropeMember nvst:EquipmentandConsumablesMember 2018-01-01 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2019-01-01 2019-09-27 0001757073 nvst:RevenuefromContractwithCustomerMeasurementRecurringMember 2018-01-01 2018-09-28 0001757073 nvst:RevenuefromContractwithCustomerMeasurementRecurringMember 2019-01-01 2019-09-27 0001757073 nvst:RevenuefromContractwithCustomerMeasurementNonrecurringMember 2019-01-01 2019-09-27 0001757073 nvst:WesternEuropeMember 2018-01-01 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember nvst:SpecialtyProductsandTechnologiesMember 2019-01-01 2019-09-27 0001757073 srt:NorthAmericaMember 2018-01-01 2018-09-28 0001757073 nvst:HighgrowthmarketsMember 2018-01-01 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:RevenuefromContractwithCustomerMeasurementRecurringMember nvst:SpecialtyProductsandTechnologiesMember 2018-01-01 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:OtherdevelopedmarketsMember nvst:EquipmentandConsumablesMember 2018-01-01 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:HighgrowthmarketsMember nvst:EquipmentandConsumablesMember 2019-01-01 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember nvst:HighgrowthmarketsMember nvst:SpecialtyProductsandTechnologiesMember 2018-01-01 2018-09-28 0001757073 nvst:OtherdevelopedmarketsMember 2019-01-01 2019-09-27 0001757073 nvst:OtherdevelopedmarketsMember 2018-01-01 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:OtherdevelopedmarketsMember nvst:SpecialtyProductsandTechnologiesMember 2019-01-01 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember nvst:WesternEuropeMember nvst:SpecialtyProductsandTechnologiesMember 2018-01-01 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:RevenuefromContractwithCustomerMeasurementRecurringMember nvst:EquipmentandConsumablesMember 2018-01-01 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:RevenuefromContractwithCustomerMeasurementNonrecurringMember nvst:SpecialtyProductsandTechnologiesMember 2018-01-01 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:WesternEuropeMember nvst:EquipmentandConsumablesMember 2019-01-01 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember nvst:EquipmentandConsumablesMember 2018-01-01 2018-09-28 0001757073 nvst:RevenuefromContractwithCustomerMeasurementNonrecurringMember 2018-01-01 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:RevenuefromContractwithCustomerMeasurementNonrecurringMember nvst:EquipmentandConsumablesMember 2019-01-01 2019-09-27 0001757073 nvst:HighgrowthmarketsMember nvst:SpecialtyProductsandTechnologiesMember 2019-06-29 2019-09-27 0001757073 nvst:OtherdevelopedmarketsMember nvst:EquipmentandConsumablesMember 2018-06-30 2018-09-28 0001757073 nvst:OtherdevelopedmarketsMember nvst:SpecialtyProductsandTechnologiesMember 2019-06-29 2019-09-27 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2018-06-30 2018-09-28 0001757073 nvst:RevenuefromContractwithCustomerMeasurementNonrecurringMember 2019-06-29 2019-09-27 0001757073 nvst:RevenuefromContractwithCustomerMeasurementRecurringMember 2019-06-29 2019-09-27 0001757073 srt:NorthAmericaMember nvst:EquipmentandConsumablesMember 2019-06-29 2019-09-27 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2019-06-29 2019-09-27 0001757073 nvst:WesternEuropeMember nvst:SpecialtyProductsandTechnologiesMember 2018-06-30 2018-09-28 0001757073 nvst:RevenuefromContractwithCustomerMeasurementNonrecurringMember nvst:EquipmentandConsumablesMember 2018-06-30 2018-09-28 0001757073 nvst:OtherdevelopedmarketsMember nvst:SpecialtyProductsandTechnologiesMember 2018-06-30 2018-09-28 0001757073 nvst:RevenuefromContractwithCustomerMeasurementRecurringMember nvst:EquipmentandConsumablesMember 2019-06-29 2019-09-27 0001757073 nvst:WesternEuropeMember nvst:SpecialtyProductsandTechnologiesMember 2019-06-29 2019-09-27 0001757073 nvst:EquipmentandConsumablesMember 2018-06-30 2018-09-28 0001757073 nvst:RevenuefromContractwithCustomerMeasurementRecurringMember nvst:SpecialtyProductsandTechnologiesMember 2018-06-30 2018-09-28 0001757073 srt:NorthAmericaMember nvst:SpecialtyProductsandTechnologiesMember 2019-06-29 2019-09-27 0001757073 srt:NorthAmericaMember 2018-06-30 2018-09-28 0001757073 nvst:HighgrowthmarketsMember nvst:EquipmentandConsumablesMember 2018-06-30 2018-09-28 0001757073 srt:NorthAmericaMember nvst:SpecialtyProductsandTechnologiesMember 2018-06-30 2018-09-28 0001757073 nvst:OtherdevelopedmarketsMember 2018-06-30 2018-09-28 0001757073 nvst:EquipmentandConsumablesMember 2019-06-29 2019-09-27 0001757073 nvst:WesternEuropeMember 2019-06-29 2019-09-27 0001757073 srt:NorthAmericaMember 2019-06-29 2019-09-27 0001757073 nvst:RevenuefromContractwithCustomerMeasurementNonrecurringMember nvst:SpecialtyProductsandTechnologiesMember 2019-06-29 2019-09-27 0001757073 nvst:RevenuefromContractwithCustomerMeasurementRecurringMember nvst:EquipmentandConsumablesMember 2018-06-30 2018-09-28 0001757073 nvst:RevenuefromContractwithCustomerMeasurementNonrecurringMember 2018-06-30 2018-09-28 0001757073 nvst:RevenuefromContractwithCustomerMeasurementRecurringMember nvst:SpecialtyProductsandTechnologiesMember 2019-06-29 2019-09-27 0001757073 nvst:HighgrowthmarketsMember 2019-06-29 2019-09-27 0001757073 nvst:OtherdevelopedmarketsMember nvst:EquipmentandConsumablesMember 2019-06-29 2019-09-27 0001757073 nvst:WesternEuropeMember nvst:EquipmentandConsumablesMember 2018-06-30 2018-09-28 0001757073 nvst:HighgrowthmarketsMember 2018-06-30 2018-09-28 0001757073 nvst:WesternEuropeMember nvst:EquipmentandConsumablesMember 2019-06-29 2019-09-27 0001757073 nvst:HighgrowthmarketsMember nvst:SpecialtyProductsandTechnologiesMember 2018-06-30 2018-09-28 0001757073 nvst:RevenuefromContractwithCustomerMeasurementNonrecurringMember nvst:EquipmentandConsumablesMember 2019-06-29 2019-09-27 0001757073 nvst:OtherdevelopedmarketsMember 2019-06-29 2019-09-27 0001757073 nvst:HighgrowthmarketsMember nvst:EquipmentandConsumablesMember 2019-06-29 2019-09-27 0001757073 srt:NorthAmericaMember nvst:EquipmentandConsumablesMember 2018-06-30 2018-09-28 0001757073 nvst:WesternEuropeMember 2018-06-30 2018-09-28 0001757073 nvst:RevenuefromContractwithCustomerMeasurementNonrecurringMember nvst:SpecialtyProductsandTechnologiesMember 2018-06-30 2018-09-28 0001757073 nvst:RevenuefromContractwithCustomerMeasurementRecurringMember 2018-06-30 2018-09-28 0001757073 srt:MaximumMember 2019-09-27 0001757073 nvst:EquipmentandConsumablesMember 2018-12-31 0001757073 nvst:EquipmentandConsumablesMember 2019-09-27 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2019-09-27 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2018-12-31 0001757073 us-gaap:LiabilityMember us-gaap:FairValueInputsLevel2Member 2019-09-27 0001757073 us-gaap:AssetsMember us-gaap:FairValueInputsLevel2Member 2019-09-27 0001757073 us-gaap:LiabilityMember us-gaap:FairValueInputsLevel3Member 2019-09-27 0001757073 us-gaap:AssetsMember us-gaap:FairValueInputsLevel3Member 2019-09-27 0001757073 us-gaap:LiabilityMember 2019-09-27 0001757073 us-gaap:LiabilityMember us-gaap:FairValueInputsLevel1Member 2019-09-27 0001757073 us-gaap:LiabilityMember us-gaap:FairValueInputsLevel1Member 2018-12-31 0001757073 us-gaap:LiabilityMember 2018-12-31 0001757073 us-gaap:AssetsMember 2019-09-27 0001757073 us-gaap:AssetsMember us-gaap:FairValueInputsLevel1Member 2019-09-27 0001757073 us-gaap:LiabilityMember us-gaap:FairValueInputsLevel3Member 2018-12-31 0001757073 us-gaap:LiabilityMember us-gaap:FairValueInputsLevel2Member 2018-12-31 0001757073 us-gaap:AssetsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-09-27 0001757073 us-gaap:LiabilityMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-09-27 0001757073 us-gaap:LiabilityMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-09-27 0001757073 us-gaap:AssetsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-09-27 0001757073 nvst:EuroTermLoanDue2022Member 2019-09-27 0001757073 nvst:USTermLoandue2022Member 2019-09-27 0001757073 us-gaap:OtherDebtSecuritiesMember 2019-09-27 0001757073 srt:MaximumMember 2019-01-01 2019-09-27 0001757073 nvst:EuroTermLoanDue2022Member 2019-01-01 2019-09-27 0001757073 2019-09-01 2019-09-30 0001757073 srt:MaximumMember us-gaap:BaseRateMember 2019-01-01 2019-09-27 0001757073 nvst:USTermLoandue2022Member 2019-01-01 2019-09-27 0001757073 srt:MinimumMember nvst:CreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-09-27 0001757073 srt:MinimumMember us-gaap:BaseRateMember 2019-01-01 2019-09-27 0001757073 us-gaap:RevolvingCreditFacilityMember nvst:SwinglineLoanMember 2019-09-27 0001757073 us-gaap:RevolvingCreditFacilityMember 2019-09-27 0001757073 us-gaap:RevolvingCreditFacilityMember us-gaap:StandbyLettersOfCreditMember 2019-09-27 0001757073 srt:MinimumMember 2019-01-01 2019-09-27 0001757073 srt:MaximumMember nvst:CreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-09-27 0001757073 nvst:EuroTermLoanDue2022Member 2019-06-29 2019-09-27 0001757073 nvst:USTermLoandue2022Member 2019-06-29 2019-09-27 0001757073 nvst:USTermLoandue2022Member 2019-09-20 2019-09-20 0001757073 nvst:EuroTermLoanDue2022Member 2019-09-20 2019-09-20 0001757073 nvst:EuroTermLoanDue2022Member 2018-12-31 0001757073 nvst:USTermLoandue2022Member 2018-12-31 0001757073 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2019-09-27 0001757073 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2019-09-27 0001757073 us-gaap:LongTermDebtMember 2019-09-27 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-09-27 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2019-09-27 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2019-06-29 2019-09-27 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2019-09-27 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-06-29 2019-09-27 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2019-06-29 2019-09-27 0001757073 us-gaap:PensionPlansDefinedBenefitMember 2019-09-27 0001757073 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-06-29 2019-09-27 0001757073 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-09-28 0001757073 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-27 0001757073 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-06-30 2018-09-28 0001757073 us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-28 0001757073 us-gaap:PensionPlansDefinedBenefitMember 2019-06-29 2019-09-27 0001757073 us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 2018-09-28 0001757073 2019-01-01 2019-03-29 0001757073 2019-03-30 2019-06-28 0001757073 us-gaap:RestrictedStockUnitsRSUMember 2019-06-29 2019-09-27 0001757073 us-gaap:EmployeeStockOptionMember 2018-06-30 2018-09-28 0001757073 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-27 0001757073 us-gaap:EmployeeStockOptionMember 2019-06-29 2019-09-27 0001757073 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-27 0001757073 us-gaap:RestrictedStockUnitsRSUMember 2018-06-30 2018-09-28 0001757073 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-09-28 0001757073 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-09-28 0001757073 us-gaap:CommonStockMember 2018-01-01 2018-09-28 0001757073 us-gaap:CommonStockMember 2018-06-30 2018-09-28 0001757073 us-gaap:RestrictedStockUnitsRSUMember 2019-09-27 0001757073 us-gaap:EmployeeStockOptionMember 2019-09-27 0001757073 srt:AffiliatedEntityMember 2019-09-27 0001757073 srt:AffiliatedEntityMember 2019-01-01 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2018-06-30 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2018-06-30 2018-09-28 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2019-06-29 2019-09-27 0001757073 us-gaap:CorporateNonSegmentMember 2019-06-29 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2019-06-29 2019-09-27 0001757073 us-gaap:CorporateNonSegmentMember 2018-06-30 2018-09-28 0001757073 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-09-28 0001757073 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-09-27 0001757073 us-gaap:CorporateNonSegmentMember 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2019-09-27 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2018-12-31 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2019-09-27 0001757073 us-gaap:CorporateNonSegmentMember 2018-12-31 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2018-12-31 0001757073 nvst:DanaherMember 2019-09-27 0001757073 srt:AffiliatedEntityMember 2019-09-20 2019-09-20 0001757073 nvst:InsuranceprogramexpensesMember srt:AffiliatedEntityMember 2019-06-29 2019-09-27 0001757073 us-gaap:DeferredCompensationShareBasedPaymentsMember srt:AffiliatedEntityMember 2019-01-01 2019-09-27 0001757073 nvst:MedicalinsuranceprogramsexpenseMember srt:AffiliatedEntityMember 2018-06-30 2018-09-28 0001757073 nvst:MedicalinsuranceprogramsexpenseMember srt:AffiliatedEntityMember 2019-06-29 2019-09-27 0001757073 srt:AffiliatedEntityMember 2018-06-30 2018-09-28 0001757073 us-gaap:GeneralAndAdministrativeExpenseMember srt:AffiliatedEntityMember 2019-06-29 2019-09-27 0001757073 us-gaap:GeneralAndAdministrativeExpenseMember srt:AffiliatedEntityMember 2019-01-01 2019-09-27 0001757073 us-gaap:DeferredCompensationShareBasedPaymentsMember srt:AffiliatedEntityMember 2018-01-01 2018-09-28 0001757073 us-gaap:GeneralAndAdministrativeExpenseMember srt:AffiliatedEntityMember 2018-01-01 2018-09-28 0001757073 us-gaap:DeferredCompensationShareBasedPaymentsMember srt:AffiliatedEntityMember 2018-06-30 2018-09-28 0001757073 srt:AffiliatedEntityMember 2019-06-29 2019-09-27 0001757073 nvst:InsuranceprogramexpensesMember srt:AffiliatedEntityMember 2018-06-30 2018-09-28 0001757073 nvst:InsuranceprogramexpensesMember srt:AffiliatedEntityMember 2019-01-01 2019-09-27 0001757073 nvst:MedicalinsuranceprogramsexpenseMember srt:AffiliatedEntityMember 2018-01-01 2018-09-28 0001757073 us-gaap:DeferredCompensationShareBasedPaymentsMember srt:AffiliatedEntityMember 2019-06-29 2019-09-27 0001757073 nvst:InsuranceprogramexpensesMember srt:AffiliatedEntityMember 2018-01-01 2018-09-28 0001757073 srt:AffiliatedEntityMember 2018-01-01 2018-09-28 0001757073 us-gaap:GeneralAndAdministrativeExpenseMember srt:AffiliatedEntityMember 2018-06-30 2018-09-28 0001757073 nvst:MedicalinsuranceprogramsexpenseMember srt:AffiliatedEntityMember 2019-01-01 2019-09-27 iso4217:USD nvst:Business_Segments iso4217:EUR iso4217:USD xbrli:shares xbrli:shares xbrli:pure nvst:Segment
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ________________________________________________________
FORM 10-Q
 ________________________________________________________
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 27, 2019
OR
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             
Commission File Number: 001-39054
envistalogoa02.jpg
ENVISTA HOLDINGS CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
 
83-2206728
(State of Incorporation)
 
(I.R.S. Employer Identification Number)
 
 
 
200 S. Kraemer Blvd., Building E
 
92821-6208
Brea,
California
 
(Address of Principal Executive Offices)
 
(Zip Code)
Registrant’s telephone number, including area code: 714-817-7000 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, $0.01 par value
NVST
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  


Table of Contents

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
 
Accelerated filer
 
 
 
 
 
Non-accelerated filer
 
 
Smaller reporting company
 
 
 
 
 
 
 
 
Emerging growth company
 
 
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)    Yes      No  
The number of shares of common stock outstanding at October 18, 2019 was 158,651,200.




Table of Contents

ENVISTA HOLDINGS CORPORATION
INDEX
FORM 10-Q
 
 
Page
PART I -
FINANCIAL INFORMATION
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART II -
OTHER INFORMATION
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


Table of Contents


ENVISTA HOLDINGS CORPORATION
CONSOLIDATED AND COMBINED CONDENSED BALANCE SHEETS
($ in millions, except per share amounts)
(unaudited)
 
September 27, 2019
 
December 31, 2018
ASSETS
 
 
 
Current assets:
 
 
 
Cash and equivalents
$
193.2

 
$

Trade accounts receivable, net
456.4

 
459.8

Inventories:
 
 
 
Finished goods
176.5

 
166.8

Work in process
31.7

 
34.3

Raw materials
70.2

 
77.6

Total inventories
278.4

 
278.7

Prepaid expenses and other current assets
50.5

 
48.3

Total current assets
978.5

 
786.8

Property, plant and equipment, net of accumulated depreciation of $394.2 and $375.2, respectively
283.1

 
261.6

Other long-term assets
282.5

 
77.4

Goodwill
3,283.2

 
3,325.5

Other intangible assets, net
1,291.1

 
1,390.3

Total assets
$
6,118.4

 
$
5,841.6

LIABILITIES AND EQUITY
 
 
 
Current liabilities:
 
 
 
Short-term debt
$
7.5

 
$

Trade accounts payable
181.4

 
217.4

Accrued expenses and other liabilities
571.8

 
423.6

Total current liabilities
760.7

 
641.0

Other long-term liabilities
539.2

 
374.2

Long-term debt
1,304.5

 

Equity:
 
 
 
Preferred stock, without par value, 15.0 million shares authorized; no shares issued or outstanding at September 27, 2019 and December 31, 2018

 

Common stock - $0.01 par value, 500.0 million shares authorized; 158.7 million shares issued and outstanding at September 27, 2019; 100 shares issued and outstanding at December 31, 2018
1.6

 

Additional paid-in capital
3,613.6

 

Retained earnings
37.0

 

Net parent investment

 
4,901.3

Accumulated other comprehensive loss
(140.9
)
 
(78.2
)
Total Envista equity
3,511.3

 
4,823.1

Noncontrolling interests
2.7

 
3.3

Total equity
3,514.0

 
4,826.4

Total liabilities and equity
$
6,118.4

 
$
5,841.6

 See the accompanying Notes to the Consolidated and Combined Condensed Financial Statements.


1

Table of Contents

ENVISTA HOLDINGS CORPORATION
CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF EARNINGS
($ and shares in millions, except per share amounts)
(unaudited)
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Sales
$
659.3

 
$
679.5

 
$
2,031.1

 
$
2,085.5

Cost of sales
(292.3
)
 
(298.6
)
 
(907.4
)
 
(905.9
)
Gross profit
367.0

 
380.9

 
1,123.7

 
1,179.6

Operating costs:
 
 
 
 
 
 
 
Selling, general and administrative expenses
(252.0
)
 
(257.2
)
 
(804.9
)
 
(820.4
)
Research and development expenses
(36.3
)
 
(42.3
)
 
(119.3
)
 
(128.4
)
Operating profit
78.7

 
81.4

 
199.5

 
230.8

Nonoperating income (expense):
 
 
 
 
 
 
 
Other income
0.2

 
1.5

 
1.6

 
1.9

Interest expense, net
(0.2
)
 

 
(0.2
)
 

Earnings before income taxes
78.7

 
82.9

 
200.9

 
232.7

Income taxes
(16.6
)
 
(18.8
)
 
(39.4
)
 
(53.2
)
Net earnings
$
62.1

 
$
64.1

 
$
161.5

 
$
179.5

Net earnings per share:
 
 
 
 
 
 
 
Basic
$
0.48

 
$
0.50

 
$
1.25

 
$
1.40

Diluted
$
0.48

 
$
0.50

 
$
1.25

 
$
1.40

Average common stock and common equivalent shares outstanding:
 
 
 
 
 
 
 
Basic
130.6

 
127.9

 
128.8

 
127.9

Diluted
130.6

 
127.9

 
128.8

 
127.9

See the accompanying Notes to the Consolidated and Combined Condensed Financial Statements.



2

Table of Contents

ENVISTA HOLDINGS CORPORATION
CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
($ in millions)
(unaudited)
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Net earnings
$
62.1

 
$
64.1

 
$
161.5

 
$
179.5

Other comprehensive loss, net of income taxes:
 
 
 
 
 
 
 
Foreign currency translation adjustments
(54.9
)
 
(17.3
)
 
(61.5
)
 
(72.0
)
Cash flow hedge adjustments
(0.6
)
 

 
(0.6
)
 

Pension plan adjustments

 
(0.8
)
 
(0.6
)
 
(0.4
)
Total other comprehensive loss, net of income taxes
(55.5
)
 
(18.1
)
 
(62.7
)
 
(72.4
)
Comprehensive income
$
6.6

 
$
46.0

 
$
98.8

 
$
107.1

 
See the accompanying Notes to the Consolidated and Combined Condensed Financial Statements.



3

Table of Contents

ENVISTA HOLDINGS CORPORATION
CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF CHANGES IN EQUITY
($ in millions)
(unaudited) 
 
Three-Month Period Ended
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
 
September 27, 2019
 
September 28, 2018
Common stock
 
 
 
 
 
 
 
Balance, beginning of period
$

 
$

 
$

 
$

Issuance of common stock
1.6

 

 
1.6

 

Balance, end of period
$
1.6

 
$

 
$
1.6

 
$

Additional paid-in capital
 
 
 
 
 
 
 
Balance, beginning of period
$

 
$

 
$

 
$

Common stock-based award activity
0.5

 

 
0.5

 

Consideration to Danaher in connection with the Separation
(1,950.0
)
 

 
(1,950.0
)
 

Reclassification of net parent investment
4,920.0

 

 
4,920.0

 

Issuance of common stock
643.1

 

 
643.1

 

Balance, end of period
$
3,613.6

 
$

 
$
3,613.6

 
$

Retained earnings
 
 
 
 
 
 
 
Balance, beginning of period
$

 
$

 
$

 
$

Net earnings
37.0

 

 
37.0

 

Balance, end of period
$
37.0

 
$

 
$
37.0

 
$

Net parent investment
 
 
 
 
 
 
 
Balance, beginning of period
$
4,938.8

 
$
5,003.7

 
$
4,901.3

 
$
4,989.9

Adoption of accounting standards

 

 

 
(8.0
)
Net earnings
25.1

 
64.1

 
124.5

 
179.5

Net transfers to parent
(45.7
)
 
(70.6
)
 
(116.5
)
 
(170.0
)
Reclassification of net parent investment
(4,921.3
)
 

 
(4,921.3
)
 

Parent common stock-based award activity
3.1

 
3.7

 
12.0

 
9.5

Balance, end of period
$

 
$
5,000.9

 
$

 
$
5,000.9

Accumulated other comprehensive loss
 
 
 
 
 
 
 
Balance, beginning of period
$
(85.4
)
 
$
(53.9
)
 
$
(78.2
)
 
$
0.6

Adoption of accounting standards

 

 

 
(0.2
)
Other comprehensive loss
(55.5
)
 
(18.1
)
 
(62.7
)
 
(72.4
)
Balance, end of period
$
(140.9
)
 
$
(72.0
)
 
$
(140.9
)
 
$
(72.0
)
Noncontrolling interests
 
 
 
 
 
 
 
Balance, beginning of period
$
2.9

 
$
3.7

 
$
3.3

 
$
4.1

Change in noncontrolling interests
(0.2
)
 
(0.3
)
 
(0.6
)
 
(0.7
)
Balance, end of period
$
2.7

 
$
3.4

 
$
2.7

 
$
3.4

Total equity, end of period
$
3,514.0

 
$
4,932.3

 
$
3,514.0

 
$
4,932.3

 See the accompanying Notes to the Consolidated and Combined Condensed Financial Statements.


4

Table of Contents

ENVISTA HOLDINGS CORPORATION
CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF CASH FLOWS
($ in millions)
(unaudited)
 
Nine-Month Period Ended
 
September 27, 2019
 
September 28, 2018
Cash flows from operating activities:
 
 
 
Net earnings
$
161.5

 
$
179.5

Noncash items:
 
 
 
Depreciation
29.8

 
29.1

Amortization
67.3

 
68.0

Stock-based compensation expense
12.5

 
9.5

Change in trade accounts receivable, net
(4.0
)
 
(9.0
)
Change in inventories
(4.5
)
 
(27.7
)
Change in trade accounts payable
(32.9
)
 
(29.0
)
Change in prepaid expenses and other assets
(9.7
)
 
6.8

Change in accrued expenses and other liabilities
(9.5
)
 
(16.7
)
Net cash provided by operating activities
210.5

 
210.5

Cash flows from investing activities:
 
 
 
Payments for additions to property, plant and equipment
(61.9
)
 
(40.2
)
Proceeds from sales of property, plant and equipment
1.6

 

All other investing activities
(2.3
)
 
(0.3
)
Net cash used in investing activities
(62.6
)
 
(40.5
)
Cash flows from financing activities:
 
 
 
Proceeds from the public offering of common stock, net of issuance costs
643.4

 

Consideration to Danaher in connection with the Separation
(1,950.0
)
 

Net proceeds from borrowings
1,319.1

 

Net transfers to parent
(116.5
)
 
(170.0
)
All other financing activities
144.4

 

Net cash provided by (used in) financing activities
40.4

 
(170.0
)
Effect of exchange rate changes on cash and cash equivalents
4.9

 

Net change in cash and equivalents
193.2

 

Beginning balance of cash and equivalents

 

Ending balance of cash and equivalents
$
193.2

 
$

 
 
 
 
Supplemental disclosures:
 
 
 
Cash income tax payments
$
28.5

 
$
31.3

Cash interest payments

 

See the accompanying Notes to the Consolidated and Combined Condensed Financial Statements.



5

Table of Contents

ENVISTA HOLDINGS CORPORATION
NOTES TO CONSOLIDATED AND COMBINED CONDENSED FINANCIAL STATEMENTS
(unaudited)

NOTE 1. BUSINESS OVERVIEW AND BASIS OF PRESENTATION
Separation and Initial Public Offering
Envista Holdings Corporation (together with its subsidiaries, “Envista” or the “Company”) was formed as a wholly-owned subsidiary of Danaher Corporation (“Danaher” or “Parent”). Danaher formed Envista to ultimately acquire, own and operate the Dental business of Danaher. On September 20, 2019, the Company completed an initial public offering (“IPO”) resulting in the issuance of 30.8 million shares of its common stock (including shares issued pursuant to the underwriters’ option to purchase additional shares) to the public, which represented 19.4% of the Company’s outstanding common stock, at $22.00 per share, the initial public offering price for total net proceeds, after deducting underwriting discounts and commissions, of $643 million. In connection with the completion of the IPO, through a series of equity and other transactions, Danaher transferred substantially all of its Dental business to the Company. As consideration for the transfer of the Dental business to the Company, the Company paid to Danaher approximately $2.0 billion, which included the net proceeds from the IPO and the net proceeds from term debt financing, as further discussed in Note 6, and issued to Danaher 127.9 million shares of the Company’s common stock. Danaher held 80.6% of the Company’s outstanding common stock as of October 18, 2019, giving Danaher 80.6% of the total voting power of the Company’s outstanding common stock. The transactions described above related to the transfer of the Dental business are collectively referred to herein as the “Separation.” As the majority stockholder, Danaher has the ability to control the outcome of matters submitted to the Company’s stockholders for approval, including the election of directors, amendments of the Company’s organizational documents and any merger, consolidation, sale of all or substantially all of the Company’s assets or other major corporate transactions.
Danaher has informed the Company that it intends to distribute to its stockholders its remaining equity interest in the Company, which may include the spin-off of Envista shares effected as a dividend to all of Danaher’s stockholders, the split-off of Envista shares in exchange for Danaher shares or other securities or any combination thereof in one transaction or in a series of transactions (collectively, the “Distribution”). While Danaher has informed the Company of its intention to effect the Distribution, it has no obligation to pursue or consummate any further dispositions of its ownership in Envista, including through the Distribution, by any specified date or at all. If pursued, the Distribution may be subject to various conditions, including receipt of any necessary regulatory or other approvals, the existence of satisfactory market conditions and the receipt of an opinion of counsel to the effect that the separation of Envista in connection with the IPO, together with such Distribution, will be tax-free to Danaher and its stockholders for U.S. federal income tax purposes. The conditions to the Distribution may not be satisfied; Danaher may decide not to consummate the Distribution even if the conditions are satisfied; or Danaher may decide to waive one or more of these conditions and consummate the Distribution even if all of the conditions are not satisfied. The Company cannot provide any assurance as to whether or when any such transaction will be consummated or as to the final terms of any such transaction.
Business Overview
The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a leading worldwide provider of a broad range of dental implants, orthodontic appliances, general dental consumables, equipment and services and is dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity.
The Company operates in two business segments: Specialty Products & Technologies and Equipment & Consumables.
The Company’s Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products.
The Company’s Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

6

Table of Contents

Basis of Presentation
For periods after the Separation, the financial statements are prepared on a consolidated basis. Prior to the Separation, the Company operated as part of Danaher and not as a separate, publicly-traded company and the Company’s financial statements are combined, have been prepared on a stand-alone basis and are derived from Danaher's consolidated financial statements and accounting records. The Consolidated and Combined Condensed Financial Statements reflect the financial position, results of operations and cash flows related to the Dental business that was transferred to the Company. All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included as a component in the financial statements. Prior to the Separation, the financial statements also include allocations of certain general, administrative, sales and marketing expenses and cost of sales from Danaher’s corporate office and from other Danaher businesses to the Company and allocations of related assets, liabilities and Danaher’s investment, as applicable. The allocations were determined on a reasonable basis; however, the amounts are not necessarily representative of the amounts that would have been reflected in the financial statements had the Company been an entity that operated independently of Danaher. Related-party allocations are discussed further in Note 15.
Prior to the Separation, the Company was dependent upon Danaher for all of its working capital and financing requirements under Danaher’s centralized approach to cash management and financing of its operations. Financial transactions relating to the Company were accounted for through the net parent investment account of the Company. Accordingly, none of Danaher’s cash, cash equivalents or debt was assigned to the Company in these financial statements for the periods prior to the Separation.
The cash balance presented on the Consolidated and Combined Condensed Balance Sheet as of September 27, 2019 of $193.2 million represents amounts contributed to Envista by Danaher as part of the Separation, as described above, and cash from operations post-Separation. The proceeds from the IPO and the term debt borrowings were distributed to Danaher pursuant to the Separation.
Net parent investment, which included retained earnings, represented Danaher’s interest in the recorded net assets of the Company. Prior to the Separation, all significant transactions between the Company and Danaher have been included in the accompanying Consolidated and Combined Condensed Financial Statements. Transactions with Danaher are reflected in the accompanying Consolidated and Combined Condensed Statements of Changes in Equity as “Net transfers to Parent” and in the accompanying Consolidated and Combined Condensed Balance Sheets within “Net parent investment.”
Sales to the Company’s largest customer were 13% of total sales during each of the three-month periods ended September 27, 2019 and September 28, 2018 and 12% during each of the nine-month periods ended September 27, 2019 and September 28, 2018. No other individual customer accounted for more than 10% of total sales during these periods. Accounts receivable from this customer was 8% of total receivables for each of September 27, 2019 and December 31, 2018.
All significant intercompany accounts and transactions between the businesses comprising the Company have been eliminated in the accompanying Consolidated and Combined Condensed Financial Statements.
The Consolidated and Combined Condensed Financial Statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s combined financial statements and accompanying notes for the three years ended December 31, 2018 included in the final prospectus (File No. 333-232758) filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”) on September 18, 2019 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended (the “Securities Act”) (the “Prospectus”).
In the opinion of the Company, the accompanying financial statements contain all adjustments (consisting of only normal recurring accruals) necessary to present fairly the financial position of the Company as of September 27, 2019 and December 31, 2018, and its results of operations for the three and nine-month periods ended September 27, 2019 and September 28, 2018 and its cash flows for each of the nine-month periods then ended.
Accounting Standards Recently Adopted—In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), which requires lessees to recognize a right-of-use (“ROU”) asset and a lease liability for all leases with terms greater than 12 months and also requires disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as “ASC 842.”

7

Table of Contents

On January 1, 2019, the Company adopted ASC 842 using the modified retrospective method for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company’s historic accounting under Accounting Standards Codification (“ASC”) 840, Leases. The adoption of ASC 842 had a material impact on the Company’s Consolidated and Combined Condensed Balance Sheet but did not have a significant impact on the Company’s consolidated and combined net earnings and cash flows. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases, while the accounting for finance leases remained substantially unchanged. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to include leases with a term of 12 months or less in the recognized ROU assets and lease liabilities.
As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of $182 million and operating lease liabilities of $191 million as of January 1, 2019, primarily related to real estate and automobile leases, based on the present value of the future lease payments on the date of adoption. Refer to Note 3 for the additional disclosures required by ASC 842.
The Company determines if an arrangement is a lease at inception. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company used Danaher’s incremental borrowing rate (for the period prior to the Separation) and its incremental borrowing rate (for the period after Separation) based on the information available at commencement date in determining the present value of lease payments. The ROU asset includes prepaid lease payments, lease incentives received, costs which will be incurred in exiting a lease and the amount of any asset or liability recognized on business combinations relating to favorable or unfavorable lease terms. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component.
In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, which expands and refines hedge accounting for both financial and non-financial risk components, aligns the recognition and presentation of the effects of hedging instruments and hedge items in the financial statements and includes certain targeted improvements to ease the application of current guidance related to the assessment of hedge effectiveness. The ASU was effective for public entities for fiscal years beginning after December 15, 2018. The Company adopted this guidance on January 1, 2019 and there was no impact on the Company’s consolidated and combined financial statements. Refer to Note 7 for additional disclosures about the Company’s hedging activities.
Except for the above accounting policy for leases that was updated as a result of adopting ASC 842 and the derivatives and hedging policy discussed in Note 7, there have been no changes to the Company’s significant accounting policies described in the Prospectus for the year ended December 31, 2018 that have a material impact on the Company’s Consolidated and Combined Condensed Financial Statements.
Accounting Standards Not Yet Adopted—In August 2018, the FASB issued ASU No. 2018-14, Disclosure FrameworkChanges to the Disclosure Requirements for Defined Benefit Plans, which amends ASC 715 to add, remove and clarify disclosure requirements related to defined benefit pension plans. The ASU is effective for public entities for fiscal years beginning after December 15, 2020, with early adoption permitted. Management has not yet completed its assessment of the impact of the new standard on the Company’s consolidated financial statements.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820), which modifies the disclosures on fair value measurements by removing the requirement to disclose the amount and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy and the policy for timing of such transfers. The ASU expands the disclosure requirements for Level 3 fair value measurements, primarily focused on changes in unrealized gains and losses included in other comprehensive income (loss). The ASU is effective for public entities for fiscal years beginning after December 15, 2019, with early adoption permitted. Management has not yet completed its assessment of the impact of the new standard on the Company’s consolidated financial statements.

8

Table of Contents

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. The ASU is effective for public entities for fiscal years beginning after December 15, 2019, with early adoption permitted. The ASU will be adopted using a modified retrospective transition method, with the adoption impact recognized through a cumulative-effect adjustment to retained earnings in the period of adoption. In November 2018, April 2019 and May 2019, the FASB issued ASU No. 2018-19, Codification Improvements to Topic 326, Financial Instruments—Credit Losses, ASU No. 2019-04, Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments and ASU No. 2019-05, Financial Instruments—Credit Losses (Topic 326): Targeted Transition Relief which provided additional implementation guidance on the previously issued ASU. Management has not yet completed its assessment of the impact of the new standard on the Company’s consolidated financial statements. The Company is in the process of implementing changes to its accounting policies and procedures for the new standard. Currently, the Company believes that the most notable impact of this ASU will relate to its processes around the assessment of the adequacy of its allowance for doubtful accounts on trade accounts receivable and the recognition of credit losses.
Accumulated Other Comprehensive Income (Loss)The changes in accumulated other comprehensive income (loss) by component are summarized below ($ in millions). Foreign currency translation adjustments generally relate to indefinite investments in non-U.S. subsidiaries and the impact from the Company’s hedge of its net investment in foreign operations, including the Company’s cross-currency swap derivatives, net of any income tax impact.
 
Foreign
Currency
Translation
Adjustments
 
Cash Flow Hedge Adjustments
 
Pension Adjustments
 
Total
For the Three-Month Period Ended September 27, 2019:
 
 
 
 
 
 
 
Balance, June 28, 2019
$
(80.9
)
 
$

 
$
(4.5
)
 
$
(85.4
)
Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
Decrease
(53.5
)
 
(0.7
)
 

 
(54.2
)
Income tax impact
(1.4
)
 
0.1

 

 
(1.3
)
Other comprehensive income (loss) before reclassifications, net of income taxes
(54.9
)
 
(0.6
)
 

 
(55.5
)
Net current period other comprehensive (loss):
(54.9
)
 
(0.6
)
 

 
(55.5
)
Balance, September 27, 2019
$
(135.8
)
 
$
(0.6
)
 
$
(4.5
)
 
$
(140.9
)
 
 
 
 
 
 
 
 
For the Three-Month Period Ended September 28, 2018:
 
 
 
 
 
 
 
Balance, June 29, 2018
$
(43.8
)
 
$

 
$
(10.1
)
 
$
(53.9
)
Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
Decrease
(17.3
)
 

 

 
(17.3
)
Income tax impact

 

 

 

Other comprehensive income (loss) before reclassifications, net of income taxes
(17.3
)
 

 

 
(17.3
)
Amounts reclassified from accumulated other comprehensive income (loss):
 
 
 
 
 
 
 
Decrease

 

 
(1.0
)
(a)
(1.0
)
Income tax impact

 

 
0.2

 
0.2

Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes:

 

 
(0.8
)
 
(0.8
)
Net current period other comprehensive income (loss):
(17.3
)
 

 
(0.8
)
 
(18.1
)
Balance, September 28, 2018
$
(61.1
)
 
$

 
$
(10.9
)
 
$
(72.0
)
(a) This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost. Refer to Note 8 for additional details.

9

Table of Contents

 
Foreign
Currency
Translation
Adjustments
 
Cash Flow Hedge Adjustments
 
Pension Adjustments
 
Total
For the Nine-Month Period Ended September 27, 2019:
 
 
 
 
 
 
 
Balance, December 31, 2018
$
(74.3
)
 
$

 
$
(3.9
)
 
$
(78.2
)
Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
Decrease
(60.1
)
 
(0.7
)


 
(60.8
)
Income tax impact
(1.4
)
 
0.1

 

 
(1.3
)
Other comprehensive income (loss) before reclassifications, net of income taxes
(61.5
)
 
(0.6
)
 

 
(62.1
)
Amounts reclassified from accumulated other comprehensive income (loss):
 
 
 
 
 
 
 
Decrease

 

 
(0.9
)
(a)
(0.9
)
Income tax impact

 

 
0.3

 
0.3

Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes:

 

 
(0.6
)
 
(0.6
)
Net current period other comprehensive income (loss):
(61.5
)
 
(0.6
)
 
(0.6
)
 
(62.7
)
Balance, September 27, 2019
$
(135.8
)
 
$
(0.6
)
 
$
(4.5
)
 
$
(140.9
)
For the Nine-Month Period Ended September 28, 2018:
 
 
 
 
 
 
 
Balance, December 31, 2017
$
10.9

 
$

 
$
(10.3
)
 
$
0.6

Adoption of accounting standards

 

 
(0.2
)
 
(0.2
)
Balance, January 1, 2018
10.9

 

 
(10.5
)
 
0.4

Other comprehensive income (loss) before reclassifications:
 
 
 
 
 
 
 
Decrease
(72.0
)
 

 

 
(72.0
)
Income tax impact

 

 

 

Other comprehensive income (loss) before reclassifications, net of income taxes
(72.0
)
 

 

 
(72.0
)
Amounts reclassified from accumulated other comprehensive income (loss):
 
 
 
 
 
 
 
Decrease

 

 
(0.5
)
(a)
(0.5
)
Income tax impact

 

 
0.1

 
0.1

Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes:

 

 
(0.4
)
 
(0.4
)
Net current period other comprehensive income (loss):
(72.0
)
 

 
(0.4
)
 
(72.4
)
Balance, September 28, 2018
$
(61.1
)
 
$

 
$
(10.9
)
 
$
(72.0
)
(a) This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost. Refer to Note 8 for additional details.


10

Table of Contents

NOTE 2. REVENUE
The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and nine-month periods ended September 27, 2019 and September 28, 2018 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.
 
Specialty Products & Technologies
 
Equipment & Consumables
 
Total
Three-Month Period Ended September 27, 2019:
 
 
 
 
 
Geographical region:
 
 
 
 
 
North America
$
148.8

 
$
178.9

 
$
327.7

Western Europe
62.1

 
65.4

 
127.5

High-growth markets (a)
83.0

 
75.5

 
158.5

Other developed markets (a)
23.9

 
21.7

 
45.6

Total
$
317.8

 
$
341.5

 
$
659.3

 
 
 
 
 
 
Revenue type:
 
 
 
 
 
Consumables, services and spare parts
$
298.4

 
$
181.0

 
$
479.4

Equipment, software and other systems
19.4

 
160.5

 
179.9

Total
$
317.8

 
$
341.5

 
$
659.3

 
 
 
 
 
 
Three-Month Period Ended September 28, 2018:
 
 
 
 
 
Geographical region:
 
 
 
 
 
North America
$
149.9

 
$
189.9

 
$
339.8

Western Europe
66.0

 
71.2

 
137.2

High-growth markets (a)
80.1

 
79.9

 
160.0

Other developed markets (a)
22.3

 
20.2

 
42.5

Total
$
318.3

 
$
361.2

 
$
679.5

 
 
 
 
 
 
Revenue type:
 
 
 
 
 
Consumables, services and spare parts
$
299.5

 
$
178.7

 
$
478.2

Equipment, software and other systems
18.8

 
182.5

 
201.3

Total
$
318.3

 
$
361.2

 
$
679.5

(a) The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan).  The Company defines developed markets as all markets that are not high-growth markets.


11

Table of Contents

.

 
Specialty Products & Technologies
 
Equipment & Consumables
 
Total
Nine-Month Period Ended September 27, 2019:
 
 
 
 
 
Geographical region:
 
 
 
 
 
North America
$
450.7

 
$
515.7

 
$
966.4

Western Europe
234.7

 
209.0

 
443.7

High-growth markets (a)
257.8

 
232.2

 
490.0

Other developed markets (a)
70.7

 
60.3

 
131.0

Total
$
1,013.9

 
$
1,017.2

 
$
2,031.1

 
 
 
 
 
 
Revenue type:
 
 
 
 
 
Consumables, services and spare parts
$
956.6

 
$
532.7

 
$
1,489.3

Equipment, software and other systems
57.3

 
484.5

 
541.8

Total
$
1,013.9

 
$
1,017.2

 
$
2,031.1

 
 
 
 
 
 
Nine-Month Period Ended September 28, 2018:
 
 
 
 
 
Geographical region:
 
 
 
 
 
North America
$
447.1

 
$
530.1

 
$
977.2

Western Europe
253.2

 
230.1

 
483.3

High-growth markets (a)
249.2

 
242.3

 
491.5

Other developed markets (a)
73.1

 
60.4

 
133.5

Total
$
1,022.6

 
$
1,062.9

 
$
2,085.5

 
 
 
 
 
 
Revenue type:
 
 
 
 
 
Consumables, services and spare parts
$
970.5

 
$
543.0

 
$
1,513.5

Equipment, software and other systems
52.1

 
519.9

 
$
572.0

Total
$
1,022.6

 
$
1,062.9

 
$
2,085.5

(a) The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan).  The Company defines developed markets as all markets that are not high-growth markets.
The Company sells equipment to customers as well as consumables, spare parts and services. The Company’s Equipment & Consumables products include traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative products, while the Company’s equipment products include treatment units, instruments, digital imaging systems, software and other visualization and magnification systems. The Company’s Specialty Products & Technologies products include implants, prosthetics, orthodontic brackets, aligners and lab products.
Remaining performance obligations related to ASC 606, Revenue From Contracts With Customers (“ASC 606”), represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. Remaining performance obligations include noncancelable purchase orders, extended warranty and service and do not include revenue from contracts with customers with an original term of one year or less. While the r